Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Coumadin in Cerebral Venous Thrombosis
NCT03191305Unknown
- Sponsor
- Foundation University Islamabad
- Start
- Aug 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
01
Overview
Open-label trial of rivaroxaban in Cerebral venous thrombosis (CVT) (2 arms), sponsored by Foundation University Islamabad. Primary endpoint: Hemorrhage or Recurrent Cerebral Venous Thrombosis at 6 months. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
Cerebral venous thrombosis (CVT)
Beyond the preview
Go deeper on NCT03191305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03191305.